Healthcare Sales & Marketing Network News: Civacir

Searching News Database: Civacir

HSMN NewsFeed - 4 Dec 2007
Biotest Pharmaceuticals Corporation Completes Acquisition of Nabi Biologics Business Unit
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 4 Dec 2007
Biotest Pharmaceuticals Corporation Announces Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 16 Jan 2007
Nabi Biopharmaceuticals Announces Initiation of Civacir(R) Phase II 'Proof-of- Concept' Clinical Trial
Biopharmaceuticals

HSMN NewsFeed - 29 Jun 2006
Nabi Biopharmaceuticals Secures Agreement with Kedrion to Co-Develop and Commercialize Civacir(R) in Europe
Biopharmaceuticals Licensing

HSMN NewsFeed - 3 Apr 2006
Nabi Biopharmaceuticals Acquires Exclusive North American Commercialization Rights to Phase III Antibody Product for Prevention and Treatment of Rejection Following Organ Transplantation
Biopharmaceuticals

HSMN NewsFeed - 1 Feb 2006
Nabi Biopharmaceuticals Announces U.S. Fast Track Designation for Civacir to Prevent Hepatitis C Re-infection in Liver Transplants
Biopharmaceuticals FDA

HSMN NewsFeed - 30 Jan 2006
Nabi Biopharmaceuticals' Mark L. Smith Resigns as Company's CFO, Effective on or Around March 1, 2006
Biopharmaceuticals Personnel

HSMN NewsFeed - 25 Jan 2006
Nabi Biopharmaceuticals Provides Update on Strategic Direction of NicVAX(TM) Program
Biopharmaceuticals

Return to NewsFeed

Additional items found! 31

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 31 additional stories matching:
Civacir
(Password required)

FindReps - Find Great Medical Independent Sales Reps without recruiter fees.

FindReps - available on the Apple App Store for iPhone and iPad.